5
Funding Rounds
$5.1m
Money raised
Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.
5
Funding Rounds
$76.5m
Money raised
A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer.
Industries:
Location:
2
Funding Rounds
$158.0m
Money raised
Senti Biosciences is a synthetic biology company.
Industries:
Key people:
- Timothy Lu ***.**@sentibio.com
- Philip Lee ******.***@sentibio.com
- Wilson Wong
5
Funding Rounds
$111.8m
Money raised
Orig3n is a biotechnology company developing personalized regenerative medicine treatments based on patient genetic profiles.
6
Funding Rounds
$190.5m
Money raised
Kuur Therapeutics focuses on the development of CAR-NKT cell therapies platform for applications in cancer treatment.
Industries:
Location:
Key people:
8
Funding Rounds
$117.5m
Money raised
Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.
Industries:
Key people:
- Nick Taylor ******@locus-bio.com
- Paul Garofolo ****.********@locus-bio.com
- Charles Gersbach linkedin
5
Funding Rounds
$103.1m
Money raised
Promethera Biosciences is a biotechnology company developing regenerative medicine treatments for liver diseases.
Industries:
Location:
Key people:
16
Funding Rounds
$328.8m
Money raised
ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.
Location:
Key people:
- Paul Laikind **@vrtx.com
2
Funding Rounds
$13.8m
Money raised
A biopharmaceutical company developing therapeutics to attack cancer stem cells.
Industries:
Location:
Key people:
1
Funding Rounds
EpiBone is a biotechnology startup company developing bone reconstruction solutions using stem cells. Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig founded EpiBone in 2013 and the company is headquartered in New York City, New York.
Industries:
Location:
Key people:
6
Funding Rounds
$86.6m
Money raised
Prokarium is a biopharmaceutical company focused on developing vaccination and cancer immunotherapy solutions based on synthetic biology.
2
Funding Rounds
$4.5m
Money raised
Cellink AB is a biotechnology research company based in Gothenburg.
9
Funding Rounds
$262.0m
Money raised
A biotechnology company using genetic editing technologies to develop therapies for the treatment of cancer and genetic diseases.
Industries:
Location:
Key people:
2
Funding Rounds
$164.5m
Money raised
Develops novel cell and gene therapies with pharmacologic operating systems.
Industries:
Location:
Key people:
- Steve Shamah *******@obsidiantx.com
- Tariq Kassum *****@curie.bio
- Michael Gilman linkedin
2
Funding Rounds
$67.5m
Money raised
A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases
Industries:
Location:
Key people:
2
Funding Rounds
$18.1m
Money raised
A biotechnology company that develops treatments for cancer and hematologic conditions
Industries:
Location:
Key people:
4
Funding Rounds
$743.2m
Money raised
A bioinformatics company in San Francisco building data collection methods and databases that will enable machine learning algorithms in healthcare. It was founded in 2018.
Industries:
Key people:
- Daphne Koller ******@insitro.com
3
Funding Rounds
$52.0m
Money raised
3T Biosciences is a biotechnology company developing immunotherapies.
Key people:
- Marvin Gee ******.***@3tbiosciences.com
- Luke Lee ****.***@ihcfunds.com
- Leah Sibener twitter
3
Funding Rounds
$183.9m
Money raised
Bit.bio is a biotechnology company that aims to operate within human cells through means of coding and biology.
4
Funding Rounds
$5.1m
Money raised
Biological micro-pancreas for insulin-dependent diabetics company
Industries:
Key people:
5
Funding Rounds
$425.0m
Money raised
Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.
Industries:
Location:
Key people:
- Dr. Yangbing Zhao linkedin
- Dr. Bruce Levine ******@capstantx.com
- Dr. Carl H. June linkedin
4
Funding Rounds
$46.7m
Money raised
Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases.
2
Funding Rounds
$386.0m
Money raised
Focused on transforming lives of patients with immune dysfunctions and cancer
1
Funding Rounds
$5.9m
Money raised
Encellin is a biotechnology company developing diabetes therapeutics using insulin responsive cells.
1
Funding Rounds
$1.7m
Money raised
Celdara Medical is a biotechnology company helping turn academic innovations into medical products.
5
Funding Rounds
$26.0m
Money raised
DCPrime is a biotechnology company developing cancer immunotherapies.
Industries:
Location:
Key people:
1
Funding Rounds
Biotechnology company founded in 2015 that develops and commercializes synthetic lipid compounds and cancer immunotherapy agents. iOx Therapeutics is an OSI spinout.
3
Funding Rounds
$105.0m
Money raised
A biopharmaceutical company developing therapeutics for treating age-related diseases.
Industries:
Location:
Key people:
2
Funding Rounds
$105.0m
Money raised
Eureka Therapeutics is a biotechnology company developing immunotherapies for the treatment of cancer.
Industries:
Location:
2
Funding Rounds
$60.6m
Money raised
A biotechnology company developing nucleic acid immunotherapy platform and protein based vaccines
Industries:
Key people:
1
Funding Rounds
$12.8m
Money raised
Kiadis Pharma is a biotechnology company developing stem cell regenerative medicine treatments for blood cancers and blood disorders.
Industries:
Location:
Key people:
2
Funding Rounds
$82.0m
Money raised
Novadip Biosciences is a biotechnology company developing regenerative medicines using stem cells.
Industries:
Location:
Key people:
- Jean- François Pollet ********@corning.com
- Denis Dufrane *****.*******@novadip.com
1
Funding Rounds
$80.0m
Money raised
A biotechnology company developing t-cell immunotherapies therapies for the treatment of cancer. The company is headquartered in Singapore, and was founded by Malcolm Brenner and Andrew Khoo in 2011.
Industries:
Location:
Key people:
2
Funding Rounds
$177.0m
Money raised
GentiBio, Inc. is a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology.
Industries:
Location:
1
Funding Rounds
$7.0m
Money raised
Gadeta is a biotechnology company developing immunotherapies for treating cancer.
Industries:
Key people:
1
Funding Rounds
$42.2m
Money raised
Soteria Biotherapeutics is a biotechnology company developing cancer immunotherapies.
Industries:
Location:
Key people:
- Alexander Martinko linkedin
- James Wells
- Zachary Hill *****@montaratx.com
2
Funding Rounds
$110.0m
Money raised
Kyverna is a cell therapy company engineering a new class of curative living medicines for inflammatory and autoimmune diseases.
Location:
Key people:
- Jeffrey Greve *******.*****@ensocell.com
3
Funding Rounds
$73.4m
Money raised
Ossium is building the world's first bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage
Industries:
Location:
Key people:
- Kevin Caldwell *****.********@ossiumhealth.com
- Erik Woods ****.*****@ossiumhealth.com
11
Funding Rounds
$37.9m
Money raised
Immusoft is a biotechnology company developing a platform for the insertion of therapeutic genes into immune cells for the treatment of a variety of genetic diseases.
9
Funding Rounds
$59.1m
Money raised
Locate Bio is a biotechnology developing cell and gene therapies for treating damaged tissues and organs.
Industries:
Location:
Key people:
3
Funding Rounds
$17.2m
Money raised
Trailhead Biosystems is a biotechnology company developing cell therapy products.
Industries:
Location:
Key people:
2
Funding Rounds
$33.8m
Money raised
A company developing immune therapies for cancer and related diseases
Industries:
Location:
Key people:
1
Funding Rounds
$15.0m
Money raised
A Canadian biotechnology company that develops specialty cell culture media, cell isolation systems and accessory products for life science research.
Industries:
Location:
Key people:
1
Funding Rounds
$24.0m
Money raised
Gradalis is a drug manufacturer, and developer of vaccines, tools and diagnostics for the treatment of cancer.
Industries:
Location:
Key people:
4
Funding Rounds
$72.3m
Money raised
Abcuro develops immunotherapies to treat autoimmunity and cancer.
Key people:
- Alex Martin ****.******@abcuro.com
2
Funding Rounds
$112.0m
Money raised
Carisma Therapeutics is a biotechnology company founded in 2016 to bring the potheyr of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA).
Industries:
Location:
Key people:
- Regina Hodits linkedin
- Margarita Chavez linkedin
- Steven Kelly ******.*****@carismatx.com
2
Funding Rounds
$33.9m
Money raised
Refuge Biotechnologies is a biotechnology company that uses CRISPR and cell therapy technologies for treating cancer.
Industries:
Location:
Key people:
- Bing C Wang ****.****@refugebiotech.com
- Stanley Qi ***@stanford.edu
2
Funding Rounds
$173.0k
Money raised
XEME Biopharma is a biotechnology company developing therapeutic cancer vaccines and cancer immunotherapy products.
Industries:
Key people:
4
Funding Rounds
$6.0m
Money raised
AGT is developing and commercializing gene and cell therapy and targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma.
Industries:
Location:
Key people:
1
Funding Rounds
$71.5m
Money raised
A2 Biotherapeutics, Inc. is a biotechnology research company developing T-cell therapies designed to attack solid tumors while sparing normal cells
4
Funding Rounds
$1.4m
Money raised
TeVido Biodevices is a biotechnology company developing cell therapy products for restoring lost skin pigment.
Industries:
Location:
Key people:
3
Funding Rounds
$200.0m
Money raised
PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.
1
Funding Rounds
$1.5m
Money raised
StemBioSys is a biotechnology company developing regenerative medicines using stem cells.
Industries:
Location:
Key people:
8
Funding Rounds
$84.5m
Money raised
Mogrify is developing tailored cellular conversions that power future cell therapies.
Industries:
Location:
3
Funding Rounds
$13.2m
Money raised
Biosceptre is a Cambridge, Cambridgeshire-based company developing diagnostic tools and biomarkers.
Industries:
Location:
Key people:
1
Funding Rounds
$35.0m
Money raised
Tactiva Therapeutics is a biotechnology company developing cancer immunotherapies.
1
Funding Rounds
$22.0m
Money raised
Stemedica Cell Technologies is a biopharmaceutical company developing and manufacturing adult stem cells and stem cell factors for research institutions and hospitals for pre-clinical and clinical studies
Industries:
Location:
6
Funding Rounds
$37.4m
Money raised
Developer of vaccines to provide broad-spectrum protection against highly mutating respiratory viruses.
Industries:
Location:
Key people:
- Alexandre Levert *******@osivax.com
- Alexandre Le Vert *******@osivax.com
- Florence Nicolas ********@osivax.com
4
Funding Rounds
$343.1m
Money raised
Encoded Therapeutics is a developer of genomics-driven precision medicine targeting and treating genetic diseases and disorders.
Industries:
Key people:
3
Funding Rounds
$138.0m
Money raised
Pandion Therapeutics is a Cambridge, Massachusetts-based company developing modular proteins, antibodies and bispecifics for autoimmune and inflammatory diseases.
4
Funding Rounds
$2.6m
Money raised
Cytonus Therapeutics is a biotechnology company developing adaptive cellular therapies for treating immune-oncology and inflammatory diseases.
4
Funding Rounds
$193.3m
Money raised
Amunix is an immuno-oncology company focused on developing immune-activating biotherapeutics for patients with solid tumor cancers.
Industries:
Key people:
- Volker Schellenberger ******.**************@sanofi.com
1
Funding Rounds
$60.0k
Money raised
Universal Cells is a biotechnology company developing regenerative medicine using stem cells.
1
Funding Rounds
$67.0m
Money raised
Qihan Biotech is a hangzhou-based biotech company focused on organ transplantation founded in 2017 by Luhan Yang.
1
Funding Rounds
$3.4m
Money raised
Anagenesis Biotechnologies is a biotechnology company developing pre-clinical stem cell therapies for treating genetic and age-related muscle degenerative diseases.
Industries:
Location:
1
Funding Rounds
$2.5m
Money raised
Targazyme is a biotechnology company focused on improving survival and quality of life for cancer patients using stem cell transplantation, immunotherapy, regenerative medicine, and gene therapy.
2
Funding Rounds
$10.0m
Money raised
Macomics is an Edinburgh-based immuno-oncology company.
Industries:
Location:
Key people:
- Prof. Jeffrey W. Pollard *******@macomics.com
- Dr. Luca Cassetta ********@macomics.com
- Dr. Robert Haigh *****@macomics.com
1
Funding Rounds
$20.0m
Money raised
Aspect Biosystems is a 3D bioprinting founded in 2013 by Tamer Mohamed, Konrad Walus, Sam Wadsworth and Simon Beyer.
Industries:
Location:
Key people:
- Tamer Mohamed *****@aspectbiosystems.com
- Konrad Walus ******@aspectbiosystems.com
- Sam Wadsworth ***@aspectbiosystems.com
4
Funding Rounds
$241.9m
Money raised
Asklepios Biopharmaceutical is a company in North Carolina.
Location:
Key people:
- Jude Samuski ****@askbio.com
- Richard Jude Samulski ****@askbio.com
- Sheila Mikhail ********@askbio.com